Your browser doesn't support javascript.
loading
CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.
Simonsson, Maria; Veerla, Srinivas; Markkula, Andrea; Rose, Carsten; Ingvar, Christian; Jernström, Helena.
Afiliação
  • Simonsson M; Department of Clinical Sciences, Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Veerla S; Department of Clinical Sciences, Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Markkula A; Department of Clinical Sciences, Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Rose C; CREATE Health and Department of Immunotechnology, Lund University, Medicon Village, Lund, Sweden.
  • Ingvar C; Department of Clinical Sciences, Lund, Division of Surgery, Lund University and Skåne University Hospital, Lund, Sweden.
  • Jernström H; Department of Clinical Sciences, Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden. helena.jernstrom@med.lu.se.
BMC Cancer ; 16: 256, 2016 Mar 31.
Article em En | MEDLINE | ID: mdl-27029552
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aromatase / Biomarcadores Tumorais / Citocromo P-450 CYP1A2 Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aromatase / Biomarcadores Tumorais / Citocromo P-450 CYP1A2 Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article